ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 187,65
0,69%
Dow Jones
39 387,76
0,85%
DAX
18 686,60
1,07%
Brent Oil
84,145
0,23%
Bitcoin
62 668,94
-0,59%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Maxcyte Inc (MXCN)

  7. Maxcyte Inc (MXCN) Actualités

MXCN

Maxcyte (MXCN)

Maxcyte Inc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:MXCN
DateHeureSourceTitreSymboleSociété
12/03/202421h05UK RegulatoryMaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 GuidanceLSE:MXCNMaxcyte Inc
04/03/202422h05UK RegulatoryMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary ResultsLSE:MXCNMaxcyte Inc
09/02/202414h05UK RegulatoryMaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor ConferencesLSE:MXCNMaxcyte Inc
30/01/202414h05UK RegulatoryMaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for CancersLSE:MXCNMaxcyte Inc
09/08/202108h00PR Newswire (US)MaxCyte Signs Clinical and Commercial License with Sana BiotechnologyLSE:MXCNMaxcyte Inc
30/07/202117h07PR Newswire (US)DLA Piper advises underwriters of MaxCyte's upsized US IPOLSE:MXCNMaxcyte Inc
30/07/202105h05PR Newswire (US)MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select MarketLSE:MXCNMaxcyte Inc
26/07/202113h49PR Newswire (US)MaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global MarketLSE:MXCNMaxcyte Inc
12/07/202108h00PR Newswire (US)MaxCyte Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual ListingLSE:MXCNMaxcyte Inc
12/07/202108h00PR Newswire (US)Financial information in the Form S-1 registration statement and Change to Board of DirectorsLSE:MXCNMaxcyte Inc
14/05/202108h00PR Newswire (US)Proposed Dual-Listing on NasdaqLSE:MXCNMaxcyte Inc
 Showing the most relevant articles for your search:LSE:MXCN

Dernières Valeurs Consultées

EU
PX1
CAC 40
EU
ACA
Credit Agricole
EU
RI
Pernod Ricard
COIN
BTCUSD
Bitcoin
EU
ORA
Orange
EU
AI
Air Liquide
NYSE
DIS
Walt Disney
EU
DG
Vinci
EU
VIV
Vivendi
EU
BEL20
Bel 20
EU
PX4
SBF 120
NYSE
KO
Coca Cola
EU
HO
Thales
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés